• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 大流行对骨与软组织肉瘤患者咨询和诊断的影响。

Impact of COVID-19 pandemic on bone and soft tissue sarcoma patients' consultation and diagnosis.

机构信息

Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.

Department of Orthopaedic Surgery, Kyushu Rosai Hospital, Fukuoka, Japan.

出版信息

Sci Rep. 2024 Sep 4;14(1):20627. doi: 10.1038/s41598-024-71830-4.

DOI:10.1038/s41598-024-71830-4
PMID:39232087
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11374780/
Abstract

The coronavirus disease (COVID-19) pandemic negatively affected the diagnosis and treatment of several cancer types. However, this pandemic's exact impact and extent on bone and soft tissue sarcomas need to be clarified. We aimed to investigate the effect of the COVID-19 pandemic and emergency declaration by the local government on consultation behavior and clinical stage at diagnosis of bone and soft tissue sarcoma. A total of 403 patients diagnosed with bone and soft tissue sarcoma who initially visited three sarcoma treatment hospitals between January 2018 and December 2021 were included. The monthly number of newly diagnosed soft tissue sarcoma patients was reduced by 25%, and the proportion of soft tissue patients with stage IV disease at diagnosis significantly increased by 9% during the COVID-19 pandemic compared to before the COVID-19 pandemic. Furthermore, the monthly number of new primary bone and soft tissue sarcoma patients significantly decreased by 43% during the state of emergency declaration. The COVID-19 pandemic had a negative impact on soft tissue sarcoma patients' consultation behavior and increased the proportion of advanced-stage patients at initial diagnosis. An emergency declaration by the local government also negatively affected primary bone and soft tissue sarcoma patients' consultation behavior.

摘要

冠状病毒病 (COVID-19) 大流行对几种癌症的诊断和治疗产生了负面影响。然而,需要明确 COVID-19 大流行对骨和软组织肉瘤的确切影响和程度。我们旨在研究 COVID-19 大流行和当地政府宣布紧急状态对骨和软组织肉瘤的咨询行为和诊断时临床分期的影响。共纳入了 2018 年 1 月至 2021 年 12 月期间首次访问三家肉瘤治疗医院的 403 名骨和软组织肉瘤患者。COVID-19 大流行期间,新诊断的软组织肉瘤患者每月数量减少了 25%,诊断时 IV 期疾病的软组织患者比例显著增加了 9%。此外,在宣布紧急状态期间,新原发性骨和软组织肉瘤患者每月数量显著减少了 43%。COVID-19 大流行对软组织肉瘤患者的咨询行为产生了负面影响,并增加了初始诊断时晚期患者的比例。当地政府宣布紧急状态也对原发性骨和软组织肉瘤患者的咨询行为产生了负面影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5122/11374780/48be0c8c7472/41598_2024_71830_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5122/11374780/0d462f83f8a3/41598_2024_71830_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5122/11374780/7f25ae18ee63/41598_2024_71830_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5122/11374780/4321b45b0abf/41598_2024_71830_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5122/11374780/48be0c8c7472/41598_2024_71830_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5122/11374780/0d462f83f8a3/41598_2024_71830_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5122/11374780/7f25ae18ee63/41598_2024_71830_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5122/11374780/4321b45b0abf/41598_2024_71830_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5122/11374780/48be0c8c7472/41598_2024_71830_Fig4_HTML.jpg

相似文献

1
Impact of COVID-19 pandemic on bone and soft tissue sarcoma patients' consultation and diagnosis.COVID-19 大流行对骨与软组织肉瘤患者咨询和诊断的影响。
Sci Rep. 2024 Sep 4;14(1):20627. doi: 10.1038/s41598-024-71830-4.
2
Has the Affordable Care Act Been Associated with Increased Insurance Coverage and Early-stage Diagnoses of Bone and Soft-tissue Sarcomas in Adults?平价医疗法案是否与成年人的保险覆盖范围增加和骨与软组织肉瘤的早期诊断有关?
Clin Orthop Relat Res. 2021 Mar 1;479(3):493-502. doi: 10.1097/CORR.0000000000001438.
3
Alarm symptoms of soft-tissue and bone sarcoma in patients referred to a specialist center.转诊至专科医院的软组织和骨肉瘤患者的警报症状。
Acta Orthop. 2014 Dec;85(6):657-62. doi: 10.3109/17453674.2014.957086. Epub 2014 Sep 1.
4
Sarcomas of Soft Tissue and Bone.软组织和骨的肉瘤
Prog Tumor Res. 2016;43:128-41. doi: 10.1159/000447083. Epub 2016 Sep 5.
5
Surgical management of bone and soft tissue sarcomas and skeletal metastases during the COVID-19 pandemic.2019冠状病毒病大流行期间骨肉瘤、软组织肉瘤及骨转移瘤的外科治疗
Eur J Surg Oncol. 2020 Jun;46(6):1178-1179. doi: 10.1016/j.ejso.2020.04.027. Epub 2020 Apr 18.
6
The impact of a managed clinical network on referral patterns of sarcoma patients in Grampian.管理型临床网络对格兰扁肉瘤患者转诊模式的影响。
Scott Med J. 2014 May;59(2):108-13. doi: 10.1177/0036933014529241. Epub 2014 Apr 1.
7
Update on sarcomas of bone and soft tissue.骨与软组织肉瘤的最新进展
Scott Med J. 2007 May;52(2):31-5. doi: 10.1258/rsmsmj.52.2.31.
8
The Scandinavian Sarcoma Group Register.斯堪的纳维亚肉瘤研究组登记处。
Acta Orthop Scand Suppl. 1999 Jun;285:41-4. doi: 10.1080/17453674.1999.11744821.
9
Histological diagnostic discrepancy and its clinical impact in bone and soft tissue tumors referred to a sarcoma center.骨与软组织肿瘤转诊至肉瘤中心的组织学诊断差异及其临床影响。
Cancer Sci. 2024 Aug;115(8):2831-2838. doi: 10.1111/cas.16211. Epub 2024 May 19.
10
One-year mortality in patients with bone and soft tissue sarcomas as an indicator of delay in presentation.骨与软组织肉瘤患者的一年死亡率作为就诊延迟的指标。
Ann R Coll Surg Engl. 2015 Sep;97(6):425-33. doi: 10.1308/003588415X14181254790284. Epub 2015 Aug 14.

本文引用的文献

1
Changes in the Number of Gastrointestinal Cancers and Stage at Diagnosis with COVID-19 Pandemic in Japan: A Multicenter Cohort Study.日本新冠肺炎大流行期间胃肠道癌症数量及诊断分期的变化:一项多中心队列研究
Cancers (Basel). 2023 Sep 4;15(17):4410. doi: 10.3390/cancers15174410.
2
Changes in the number of cancer diagnosis practices due to the COVID-19 pandemic: interrupted time-series analysis using the National Database of Japan.由于 COVID-19 大流行,癌症诊断实践数量的变化:使用日本国家数据库进行的中断时间序列分析。
J Cancer Res Clin Oncol. 2023 Aug;149(9):6023-6033. doi: 10.1007/s00432-022-04557-2. Epub 2023 Jan 11.
3
Delay in Diagnosis and Treatment of Primary Bone Tumors during COVID-19 Pandemic in Poland.
波兰新冠疫情期间原发性骨肿瘤诊断和治疗的延迟
Cancers (Basel). 2022 Dec 8;14(24):6037. doi: 10.3390/cancers14246037.
4
Increased Delay in Diagnosis, but Not Treatment, Among Patients With Oral Cancer During the COVID-19 Pandemic.在新冠疫情期间,口腔癌患者的诊断延迟增加,但治疗延迟未增加。
JAMA Otolaryngol Head Neck Surg. 2023 Jan 1;149(1):91-92. doi: 10.1001/jamaoto.2022.3652.
5
The impact of the COVID-19 pandemic on diagnosis and treatment of patients with soft tissue and bone sarcomas or aggressive benign musculoskeletal diseases: A single-center retrospective study (SarCorD study).2019年冠状病毒病大流行对软组织和骨肉瘤或侵袭性良性肌肉骨骼疾病患者诊断和治疗的影响:一项单中心回顾性研究(SarCorD研究)
Front Oncol. 2022 Sep 20;12:1000056. doi: 10.3389/fonc.2022.1000056. eCollection 2022.
6
Rising incidence of late stage breast cancer after COVID-19 outbreak. Real-world data from the Italian COVID-DELAY study.新冠疫情后晚期乳腺癌发病率上升。来自意大利 COVID-DELAY 研究的真实世界数据。
Breast. 2022 Oct;65:164-171. doi: 10.1016/j.breast.2022.08.007. Epub 2022 Aug 18.
7
Alarming Drop in Early Stage Colorectal Cancer Diagnoses After COVID-19 Outbreak: A Real-World Analysis from the Italian COVID-DELAY Study.新冠疫情爆发后早期结直肠癌诊断数量惊人下降:来自意大利 COVID-DELAY 研究的真实世界分析。
Oncologist. 2022 Sep 2;27(9):e723-e730. doi: 10.1093/oncolo/oyac129.
8
Impact of COVID-19 pandemic on healthcare service use for non-COVID-19 patients in Japan: retrospective cohort study.COVID-19 大流行对日本非 COVID-19 患者医疗服务利用的影响:回顾性队列研究。
BMJ Open. 2022 Apr 24;12(4):e060390. doi: 10.1136/bmjopen-2021-060390.
9
The impact of the COVID-19 pandemic on cancer diagnosis based on pathology notifications: A comparison across the Nordic countries during 2020.基于病理通知的 COVID-19 大流行对癌症诊断的影响:2020 年北欧国家的比较。
Int J Cancer. 2022 Aug 1;151(3):381-395. doi: 10.1002/ijc.34029. Epub 2022 Apr 25.
10
Overview of the ethical guidelines for medical and biological research involving human subjects in Japan.日本涉及人体医学和生物学研究的伦理准则概述。
Jpn J Clin Oncol. 2022 May 31;52(6):539-544. doi: 10.1093/jjco/hyac034.